Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin

Abstract Background The CDSCO of India has authorized a combination of metformin hydrochloride, teneligliptin hydrochloride, and pioglitazone hydrochloride for the treatment of insulin-independent diabetes. For the purpose of estimating metformin, teneligliptin, and pioglitazone combinations as well...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Pintu Prajapati, Pooja Patel, Dhrumi Naik, Anzarul Haque, Shailesh Shah
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	SpringerOpen 2024-11-01
סדרה:	Future Journal of Pharmaceutical Sciences
נושאים:	Metformin hydrochloride Teneligliptin hydrobromide hydrate Pioglitazone hydrochloride Analytical quality by design Response surface modeling
גישה מקוונת:	https://doi.org/10.1186/s43094-024-00746-7
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!